Incannex Healthcare (IXHL) Competitors $1.68 -0.11 (-5.88%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends IXHL vs. PLX, SAVA, IVA, EDIT, ALGS, ABOS, MGX, LPTX, TARA, and INMBShould you be buying Incannex Healthcare stock or one of its competitors? The main competitors of Incannex Healthcare include Protalix BioTherapeutics (PLX), Cassava Sciences (SAVA), Inventiva (IVA), Editas Medicine (EDIT), Aligos Therapeutics (ALGS), Acumen Pharmaceuticals (ABOS), Metagenomi (MGX), Leap Therapeutics (LPTX), Protara Therapeutics (TARA), and INmune Bio (INMB). These companies are all part of the "pharmaceutical products" industry. Incannex Healthcare vs. Protalix BioTherapeutics Cassava Sciences Inventiva Editas Medicine Aligos Therapeutics Acumen Pharmaceuticals Metagenomi Leap Therapeutics Protara Therapeutics INmune Bio Incannex Healthcare (NASDAQ:IXHL) and Protalix BioTherapeutics (NYSE:PLX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, community ranking, institutional ownership, risk, earnings, media sentiment, dividends and valuation. Is IXHL or PLX more profitable? Incannex Healthcare has a net margin of 0.00% compared to Protalix BioTherapeutics' net margin of -21.03%. Protalix BioTherapeutics' return on equity of -30.89% beat Incannex Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Incannex HealthcareN/A -182.23% -127.38% Protalix BioTherapeutics -21.03%-30.89%-11.74% Which has more risk & volatility, IXHL or PLX? Incannex Healthcare has a beta of 7.68, meaning that its share price is 668% more volatile than the S&P 500. Comparatively, Protalix BioTherapeutics has a beta of 0.74, meaning that its share price is 26% less volatile than the S&P 500. Does the media favor IXHL or PLX? In the previous week, Protalix BioTherapeutics had 1 more articles in the media than Incannex Healthcare. MarketBeat recorded 1 mentions for Protalix BioTherapeutics and 0 mentions for Incannex Healthcare. Incannex Healthcare's average media sentiment score of 0.00 equaled Protalix BioTherapeutics'average media sentiment score. Company Overall Sentiment Incannex Healthcare Neutral Protalix BioTherapeutics Neutral Do insiders and institutionals believe in IXHL or PLX? 0.4% of Incannex Healthcare shares are owned by institutional investors. Comparatively, 16.5% of Protalix BioTherapeutics shares are owned by institutional investors. 26.5% of Incannex Healthcare shares are owned by company insiders. Comparatively, 6.3% of Protalix BioTherapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community favor IXHL or PLX? Protalix BioTherapeutics received 7 more outperform votes than Incannex Healthcare when rated by MarketBeat users. CompanyUnderperformOutperformIncannex HealthcareN/AN/AProtalix BioTherapeuticsOutperform Votes770.00% Underperform Votes330.00% Which has better earnings and valuation, IXHL or PLX? Protalix BioTherapeutics has higher revenue and earnings than Incannex Healthcare. Protalix BioTherapeutics is trading at a lower price-to-earnings ratio than Incannex Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIncannex Healthcare$86K344.65-$18.46M-$1.39-1.21Protalix BioTherapeutics$45.67M2.84$8.31M-$0.13-13.54 SummaryProtalix BioTherapeutics beats Incannex Healthcare on 8 of the 13 factors compared between the two stocks. Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Get Incannex Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for IXHL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IXHL vs. The Competition Export to ExcelMetricIncannex HealthcarePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$29.64M$6.57B$5.10B$9.08BDividend YieldN/A2.97%4.88%4.21%P/E Ratio-1.2110.5090.8317.14Price / Sales344.65195.361,112.01116.85Price / CashN/A57.1642.0237.88Price / Book9.335.104.774.78Net Income-$18.46M$151.51M$119.70M$225.60M7 Day Performance-9.68%-2.11%-1.86%-1.23%1 Month Performance-14.29%-3.11%11.45%3.07%1 Year Performance-55.08%11.53%30.43%16.48% Incannex Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IXHLIncannex HealthcareN/A$1.68-5.9%N/A-54.1%$29.64M$86,000.00-1.213PLXProtalix BioTherapeuticsN/A$1.75-2.8%N/A+2.9%$128.85M$65.49M-13.81200SAVACassava Sciences4.3986 of 5 stars$2.66-3.3%$111.50+4,091.7%-88.1%$127.97MN/A-1.9930News CoverageGap DownIVAInventiva3.124 of 5 stars$2.39-2.4%$13.25+454.4%-45.3%$125.42M$15.62M0.00100EDITEditas Medicine4.3804 of 5 stars$1.48+2.8%$7.00+373.0%-87.2%$122.17M$61.76M-0.58230High Trading VolumeALGSAligos Therapeutics4.059 of 5 stars$33.66-1.2%$75.00+122.8%+161.2%$120.77M$6.00M-2.5690News CoverageGap DownHigh Trading VolumeABOSAcumen Pharmaceuticals3.1587 of 5 stars$1.97-3.0%$9.33+373.8%-39.9%$118.36MN/A-1.4751Short Interest ↓News CoveragePositive NewsMGXMetagenomi2.1336 of 5 stars$3.11-4.0%$16.67+435.9%N/A$116.39M$55.08M0.00236High Trading VolumeLPTXLeap Therapeutics1.2946 of 5 stars$3.01+2.0%$7.50+149.2%-1.0%$115.34M$1.50M-1.5340Positive NewsGap DownTARAProtara Therapeutics2.3557 of 5 stars$5.53-7.5%$22.67+309.9%+196.2%$114.08MN/A-1.8830INMBINmune Bio1.4934 of 5 stars$5.08+6.9%$20.00+293.7%-55.7%$112.63M$42,000.00-2.1810 Related Companies and Tools Related Companies Protalix BioTherapeutics Alternatives Cassava Sciences Alternatives Inventiva Alternatives Editas Medicine Alternatives Aligos Therapeutics Alternatives Acumen Pharmaceuticals Alternatives Metagenomi Alternatives Leap Therapeutics Alternatives Protara Therapeutics Alternatives INmune Bio Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IXHL) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Incannex Healthcare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Incannex Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
